DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Uemura H, Fujimoto K, Tanaka M.
A Phase I trial of vaccination of CA9-derived peptides for
HLA-A24-positive patients with cytokine-refractory metastatic renal cell
carcinoma.
Clin Cancer Res 2006; 12: 1768-75
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.